GABPA and cancer: However, Nrf2 deregulation due to mutations after MP exposure leads to nuclear accumulation and constitutive activation in various cancer cell lines, promoting drug chemoresistance, immune defects, metabolic reprogramming, cancer growth, and metastasis [41].